Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TriFetch›
Analysis
TriFetch

TriFetch

Pre-Seed

TriFetch develops AI-powered automation for administrative workflows in independent specialty clinics.

HQ
San Francisco, CA, US
Founded
2024
Loading
Overview
Analysis
Compare
Fundraising
Employees
News

Contents

  1. 01Market Outlook
  2. 02Competitive Strengths
  3. 03Pricing Strategy
  1. 01Market Outlook
  2. 02Competitive Strengths
  3. 03Pricing Strategy

Market Outlook

TriFetch is targeting the US healthcare administrative automation market, serving independent specialty clinics across ophthalmology, cardiology, gastroenterology, dermatology, and orthopedics. The company plans to expand into multi-specialty groups, primary care, and hospital-owned networks.

The healthcare administrative automation market represents a significant opportunity as independent specialty clinics face increasing administrative burdens. TriFetch estimates that a medium-sized practice can gain 500,000 to 1.4 million dollars in annual savings through its platform.

Competitive Advantages

TriFetch's platform is EMR-agnostic and integrates with existing systems without requiring infrastructure changes or staff retraining. The company embeds staff alongside clinic teams until systems run fully, offering a one-month pilot with a money-back guarantee. The platform maintains SOC 2 and HIPAA compliance.

The platform supports multiple medical specialties including ophthalmology, cardiology, gastroenterology, dermatology, and orthopedics. It handles patient referrals, prior authorizations, scheduling, and communication through an AI voice agent named Linda.

Pricing Strategy

TriFetch offers a one-month pilot with a money-back guarantee. According to its pricing calculator, the platform costs approximately 102,000 dollars per year, with projected annual savings of 284,000 to 401,000 dollars for a medium-sized practice.

The company also provides a free ROI calculator on its website to help practices estimate potential savings from automating administrative workflows.